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Young, but not adult, fragile X mental retardation gene (Fmr1) knockout (KO) mice display
audiogenic seizures (AGS) that can be prevented by inhibiting extracellular signal-regulated
kinases 1/2 (ERK1/2) phosphorylation. In order to identify the cerebral regions involved
in these phenomena, we characterized the response to AGS in Fmr1 KO mice and wild
type (WT) controls at postnatal day (P) 45 and P90. To characterize the diverse response
to AGS in various cerebral regions, we evaluated the activity markers FosB/FosB and
phosphorylated ERK1/2 (p-ERK1/2). Wild running (100% of tested mice) followed by
clonic/tonic seizures (30%) were observed in P45 Fmr1 KO mice, but not in WT mice.
In P90 Fmr1 KO mice, wild running was only present in 25% of tested animals. Basal
FosB/FosB immunoreactivity was higher (P < 0.01 vs. WT) in the CA1 and subiculum
of P45 Fmr1 KO mice. Following the AGS test, FosB/FosB expression consistently
increased in most of the analyzed regions in both groups at P45, but not at P90.
Interestingly, FosB/FosB immunoreactivity was significantly higher in P45 Fmr1 KO mice
in the medial geniculate body (P < 0.05 vs. WT) and CA3 (P < 0.01). Neurons presenting
with immunopositivity to p-ERK1/2 were more abundant in the subiculum of Fmr1 KO
mice in control condition (P < 0.05 vs. WT, in both age groups). In this region, p-ERK1/2-
immunopositive cells significantly decreased (–75%, P < 0.01) in P90 Fmr1 KO mice
exposed to the AGS test, but no changes were found in P45 mice or in other brain
regions. In both age groups of WT mice, p-ERK1/2-immunopositive cells increased in the
subiculum after exposure to the acoustic test. Our findings illustrate that FosB/FosB
markers are overexpressed in the medial geniculate body and CA3 in Fmr1 KO mice
experiencing AGS, and that p-ERK1/2 is markedly decreased in the subiculum of Fmr1
KO mice resistant to AGS induction. These findings suggest that resilience to AGS is
associated with dephosphorylation of p-ERK1/2 in the subiculum of mature Fmr1 KOmice.
Keywords: acoustic stimulus, epilepsy, extracellular signal-regulated kinase (ERK), FosB, Fragile X Syndrome,
hippocampus, geniculate body, subiculum
INTRODUCTION
The Fragile X Syndrome (FXS) is one of the leading causes of
mental retardation (Rousseau et al., 1995; Dombrowski et al.,
2002). In FXS, CGG triplet expansion in the fragile X mental
retardation gene (Fmr1) prevents the synthesis of the fragile X
mental retardation protein (FMRP) (De Rubeis and Bagni, 2010),
causing anatomical and functional alterations, such as abnormal
dendrite spines morphology and dysfunctions in synaptic plastic-
ity (Zalfa et al., 2006). Individuals affected by FXS suffer from
mental retardation, learning disabilities, and attention deficit.
They also show behavioral problems including anxiety, autism,
hyperactivity, and aggression (Hagerman, 1996). FXS patients
may also respond to olfactory, tactile, visual, and auditory stimuli
with hyper-reactivity and convulsions (Ferri et al., 1994; Miller
et al., 1999; Berry-Kravis et al., 2010). The prevalence of epilepsy
in FXS is larger than in the normal population, ranging from 14
to 50% of FXS patients (Berry-Kravis, 2002).
Epilepsy associated with FXS is generally benign, spon-
taneously remitting during or immediately after adolescence
(Singh et al., 1999). Rolandic epileptiform potentials during
hand tapping suggest neurophysiological similarities between
FXS and benign childhood epilepsy with centrotemporal spikes
(Musumeci et al., 1994). In absence of external stimulation,
epileptic condition in FXS patients has been extensively inves-
tigated (Musumeci et al., 1988, 1991, 1999; Sabaratnam et al.,
2001; Berry-Kravis et al., 2010; Gauthey et al., 2010). Seizures in
FXS individuals appear after the age of 2 years with some cases
of late onset. They are frequently complex partial seizures, but
simple partial seizures, generalized tonic-clonic seizures, febrile
convulsions, and status epilepticus have been observed as well.
Seizure foci are commonly located in frontal or temporal lobes.
Although in most of the epileptic FXS patients seizures are
well controlled by antiepileptic drugs (Hagerman and Stafstrom,
2009), sometimes they may be frequent, severe and unresponsive
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to treatments (Sabaratnam et al., 2001; Incorpora et al., 2002).
Even when very mild and well controlled pharmacologically,
seizures may still be dangerous for FXS patients. Indeed, recently
it has been demonstrated that in an animal model of tempo-
ral lobe epilepsy (TLE), pilocarpine-treated rats experiencing
seizures show an increase in dopamine neuron activity and an
increase in amphetamine-stimulated locomotor activity, suggest-
ing that TLE-associated psychosis is probably due to abnormal
hippocampal overdrive of dopamine neuron activity (Cifelli and
Grace, 2012). In addition, a number of well-known genetic dis-
orders, including FXS, but also tuberous sclerosis complex and
Rett Syndrome, shares epilepsy, intellectual disability and autism
(Brooks-Kayal, 2011), suggesting a possible link between epilepsy
and psychiatric disorders. In recent studies it has been found
an increased incidence of seizures in individuals with FXS also
diagnosed with autism compared to FXS patients without autism
(Garcia-Nonell et al., 2008; Berry-Kravis et al., 2010). In addition,
it has been shown that in another form of mental retardation,
the Down Syndrome, cognitive deficit is more pronounced in
patients presenting epilepsy than in Down Syndrome patients
without epilepsy (Eisermann et al., 2003). These observations
suggest that early life seizures can result in cellular and molecular
changes that could contribute to learning and behavioral disabil-
ities and that, similarly to Down Syndrome, also in FXS, epilepsy
may play a crucial role in worsening cognitive functions. As elec-
troencephalographic (EEG) abnormalities have been observed
also in non-epileptic FXS patients (Berry-Kravis, 2002), and short
non-spreading events not associated with obvious clinical mani-
festations (subclinical seizures) have been demonstrated in other
forms of partial epilepsy (D’Ambrosio et al., 2009), abnormal
brain activity can actually be a problem not restricted to the 23%
of FXS population presenting with spontaneous motor seizures.
Therefore, a better understanding of epileptic activity in FXS is
crucial for improving quality of life of all FXS patients.
Fmr1 knockout (KO)mice provide a suitable animal model for
studying FXS because they reproduce the FXS phenotype (The
Dutch-Belgian Fragile X Consorthium, 1994). Although they
have not been evaluated for epilepsy prospectively by video-EEG,
the presence of age-dependent epilepsy was reported in these mice
(Musumeci et al., 1999, 2000). Similarly to FXS patients, they
are characterized by an anomalous reaction to sensory stimuli
(Musumeci et al., 2000) and show audiogenic seizures (AGS),
characterized by wild running followed by clonic, tonic-clonic,
and/or tonic convulsions in response to loud sounds (Henry,
1967; Musumeci et al., 2000; Chen and Toth, 2001). Recent
studies have demonstrated that inhibitors of extracellular signal-
regulated kinases 1/2 (ERK1/2) phosphorylation prevent AGS
induction in Fmr1 KO mice (Osterweil et al., 2010; Michalon
et al., 2012; Wang et al., 2012). In order to further investigate the
role of phosphorylated ERK1/2 (p-ERK1/2) in AGS in the FXS
mouse model, we considered two different age groups of Fmr1
KO mice and compared them with age-matched wild type (WT)
control animals. Both genotypes were exposed to the test for AGS
induction at postnatal day (P) 45 or P90. In order to verify the
effects of the testing procedure and AGS induction on neuronal
networks, we also investigated the expression of the activity mark-
ers FosB/FosB (Biagini et al., 2005, 2008), the ideal tool available
now to investigate network activity in epileptic animals (Chen
et al., 1997; Biagini et al., 2005; Madsen et al., 2006) since prod-
ucts of the fosB gene family are stable and tend to accumulate in
repeatedly activated neurons (Chen et al., 1997; Kelz and Nestler,
2000). Instead, c-Fos, another tool being used for many years to
track acute changes in neuronal network activity (Chen and Toth,
2001), is extremely short living making c-Fos reliability question-
able in cases of recurrent neuronal synchronization. In line with
the previous findings in other models of epilepsy (Biagini et al.,
2005, 2008), we found that FosB/FosB immunoreactivity was
significantly correlated with seizure induction in P45 Fmr1 KO
mice, especially in acoustic regions (medial geniculate body) and
the hippocampus proper (CA3). Interestingly, p-ERK1/2 was not
significantly changed in Fmr1 KOmice experiencing seizures, but
it was instead markedly decreased in the subiculum of P90 Fmr1
KO mice that were resistant to AGS induction. These findings
suggest that the disappearance of sensitivity to AGS during devel-
opment is associated with dephosphorylation of p-ERK1/2 in the
subiculum.
MATERIALS ANDMETHODS
ANIMALS
Male C57BL/6 WT (n = 22) and C57BL/6 Fmr1 KO mice
(n = 25) were studied at P45 (n = 25) or P90 (n = 22). Mice
were housed at the animal facility of the Montreal Neurological
Institute and sacrificed after the testing procedure. All the pro-
cedures were approved by the Canadian Council of Animal Care
and were in accordance with the European Communities Council
Directive 2010/63/EU.
AUDIOGENIC TESTS
The experimental chamber consisted in a plastic cage 25 × 25 ×
47 cm in which the doorbell (Electrical bell Heath Zenith, model
172C-A) was mounted on the cage roof. Mice were taken from
their housing room one by one, transferred into the experi-
mental chamber and allowed to explore the novel environment
(basal noise ∼65 dB) for a period of 30 s, then the bell was rung
(122 dB), while concomitant behavior was video-recorded. The
motor responses were classified using a scale modified from the
one originally described by Jobe et al. (1973): no response (NR,
in Figure 1, consisting of pause or continuous exploration), wild
running (WR, in Figure 1), clonic seizure (CS, in Figure 1), tonic
seizure (TS, in Figure 1), respiratory arrest and/or death (RA,
in Figure 1). In order to define the intensity of the behavioral
response we used the seizure severity score (SSS, in Figure 1)
(Musumeci et al., 2000), consisting of a score assigned to each ani-
mal depending on its behavioral response (NR = 0, WR = 1, CS
= 2, TS = 3, RA = 4). Mice of WT (n = 6 at P45, n = 4 at P90)
and Fmr1 KO (n = 9 at P45, n = 8 at P90) groups were exposed
to a single 60 s continuous stimulus. As controls, WT (n = 6 at
P45, n = 6 at P90) and Fmr1 KO mice (n = 4 at P45, n = 4 at
P90) were placed in the chamber but the bell was not rung.
IMMUNOHISTOCHEMISTRY AND DENSITOMETRIC ANALYSIS
Tested WT and Fmr1 KO mice, and untested WT and Fmr1
KO mice were decapitated under deep isoflurane anesthesia
14–17 h after the behavioral test. Brains were extracted and cut
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FIGURE 1 | Behavioral response to audiogenic stimuli. (A) Fmr1 KO
mice studied at postnatal day (P) 90 showed a less intense motor response
to the audiogenic stimuli (6 NR, 2 WR; n = 8) than P45 group (6 WR, 1 CS,
2 TS; n = 9), both higher than WT mice that did not respond behaviorally to
the test either at P45 nor at P90. (B) Frames obtained from the video
recordings of a P45 WT mouse during exploratory behavior (a), and of P45
Fmr1 KO mice during WR (b), Straub tail (c), TS (d). (C) The seizure severity
score (SSS) shows that the intensity of seizing in P45 Fmr1 KO mice is
6-fold higher than in P90 group, both higher than WT mice (no response).
∗∗P < 0.01, Kruskal–Wallis test followed by Dunn’s test. NR, no response;
WR, wild running; CS, clonic seizures; TS, tonic seizures; RA, respiratory
arrest.
in 1mm-thick horizontal sections using a vibratome (VT1000S
Leica, Germany); slices were fixed overnight in 4% formalde-
hyde, cryoprotected in 15 and 30% sucrose-buffered solutions,
and then stored at−80◦C. Fortyμm-thick sections were obtained
at the cryostat (Leica, Jung CM 3000, Germany) and pro-
cessed for immunohistochemistry using a rabbit polyclonal anti-
FosB/FosB (H75) antibody (sc-7203, Santa Cruz Biotechnology,
Santa Cruz, CA, USA; dilution 1:250) (Biagini et al., 2005,
2008) or a mouse monoclonal antibody against p-ERK1/2
(Thr202/Tyr204, cat-9106, Cell Signal Technology, Beverly, MA,
USA; dilution 1:1500), according to the avidin-biotin-peroxidase
complex technique and using diaminobenzidine as a chromogen
(Biagini et al., 2005, 2008). Briefly, sections were treated with
3% H2O2 in phosphate buffered saline (PBS) to block endoge-
nous peroxidase and then incubated with the primary antibody
for 48 h at 4◦C. Slices were then incubated with the secondary
antibody (dilution 1:200) for 1 h at room temperature and finally
incubated with streptavidin biotinylated horseradish peroxidase
complex (dilution 1:300) for 45min, always at room tempera-
ture.
Sections mounted on gelatin-coated slides were analyzed using
the image analysis software KS300 (Zeiss-Kontron, Munich,
Germany). Background values in stained sections were obtained
from areas that did not contain any stained cell (i.e., the angu-
lar bundle). Stained profiles were discriminated from background
throughout every sampled region (Biagini et al., 1993, 1998,
2005, 2008). Cell profile counts were determined in each field
as the number of immunopositive profiles after transformation
in D-circles (i.e., the diameter of circles having the same area as
measured) by considering a minimum cutoff value of 7μm. Cell
counts were then divided by the sampled field area and expressed
as cell densities. Sampled areas were the hippocampal regions
CA1 and CA3, dentate gyrus, presubiculum, subiculum, entorhi-
nal cortex, perirhinal cortex, lateral amygdala, primary auditory
cortex, and medial geniculate body.
IMMUNOFLUORESCENCE
Double-immunostaining experiments were performed on free
floating sections washed in PBS at room temperature and per-
meabilized for 1 h in PBS containing 0.1% Triton X-100 and
1% bovine serum albumin. For double immunolabeling, sec-
tions were incubated overnight in a mixture of the mouse
monoclonal anti-p-ERK1/2 (1:500) and the rabbit polyclonal
anti-FosB/FosB antibody (1:250). Further co-labeling experi-
ments were designed using the mouse monoclonal anti-p-ERK
(1:500) and, respectively, a rabbit polyclonal antibody against par-
valbumin (no. 235, Swant, Bellinzona, CH; diluted at 1:2000),
neuropeptide Y (no. IHC 7180, Peninsula, San Carlos, CA, USA;
diluted at 1:800), and somatostatin (no. 20089, Immunostar,
Hudson, WI, USA; diluted at 1:1000). After washing, sec-
tions were incubated for 90min at room temperature in a
1:200 dilution of goat anti-mouse AlexaFluor546® and goat
anti-rabbit AlexaFluor488® (Invitrogen, Carlsbad, California).
Sections were counterstained with 4′,6 diamidino-2-phenylindole
(DAPI, Vector Laboratories, USA) to assess nuclear morphol-
ogy. Images were visualized using a Leica TCS SP2 confocal
microscope, equipped with Argon (488 nm) and Helium/Neon
(543 nm).
STATISTICAL ANALYSIS
Data on behavioral score were analyzed with the Fisher’s test.
The seizure severity score was analyzed with Kruskal–Wallis non-
parametric analysis of variance (ANOVA), followed by post-hoc
Dunn’s test for multiple comparisons. Cell counts underwent a
Three-Way ANOVA, using as factors the genotype (WT or Fmr1
KO), the acoustic test (yes or no) and the age (P45 or P90).
Frontiers in Cellular Neuroscience www.frontiersin.org April 2013 | Volume 7 | Article 46 | 3
Curia et al. Audiogenic seizures in Fragile X Syndrome
Post-hoc test for multiple comparisons was the Fisher’s Least-
Significant-Difference (LSD). Data were analyzed with Sigmaplot
11 (Systat Software, San Jose, CA, USA). Results are shown as
mean ± standard error of the mean (SEM), and P < 0.05 was
considered statistically significant.
RESULTS
MOTOR RESPONSE ANALYSIS
Audiogenic stimulus was given once and concomitant ani-
mal behavior was observed and scored (Figure 1). The test
for AGS did not induce anomalous behaviors in WT mice
(n = 6 at P45 and n = 4 at P90; Figure 1A), which continued
to explore the novel environment (Figure 1Ba) or, sometimes,
paused. In contrast, a motor response was triggered in P45
Fmr1 KO mice (n = 9), 6 of which developed wild running
episodes (Figure 1Bb) and often presented with the Straub
tail (Figure 1Bc); one progressed from wild running to clonic
seizures, and 2 further progressed to tonic seizures (Figure 1Bd).
In P90 Fmr1 KO mice (n = 8) the response was less marked than
in P45 mice: only 2 out of 8 developed wild running episodes
(Figure 1A). All mice resumed normal behavior before the acous-
tic stimulation was over, and death due to respiratory arrest was
never observed neither in P45 nor in P90 group. Motor response
rate was 100% in P45 Fmr1 KO group (9 out of 9), 25% in P90
Fmr1 KOmice (2 out of 8) and 0% (no response) in P45 and P90
WT groups (P < 0.01, Fisher’s test).
Using a scale created for AGS (see Materials and Methods sec-
tion for details), the seizure severity score was calculated for each
group: it was 1.56 ± 0.29 in P45 Fmr1 KO mice, 0.25 ± 0.16 in
P90 Fmr1KOmice, and 0.0 in P45 and P90WTmice (Figure 1C).
The Kruskal–Wallis test revealed a significant difference between
seizure severity score at P45 and P90 Fmr1 KO mice (P < 0.01).
These findings confirm that FXS mice are more susceptible to
AGS compared to WT mice and that this susceptibility is age-
dependent, resulting more pronounced in young adult FXS mice
than in older subjects (Musumeci et al., 2000, 2007; Yan et al.,
2005).
FosB/FosB IMMUNOSTAINING
In order to disclose the neuronal networks mediating AGS,
we mapped FosB/FosB expression in activated neurons in
hippocampal (Sub, CA1, CA3, DG in Figures 2A,B), parahip-
pocampal (preSub, EC in Figures 2A,C) and extrahippocampal
regions (LA in Figures 2A,C), including the auditory pathways
(MGB, Au1 in Figures 3A,B). FosB/FosB immunoreactivity
was barely detectable in P45 WT mice in control condition
FIGURE 2 | Changes in limbic FosB/FosB immunoreactivity
determined by exposure to a test for audiogenic seizure induction
and in relation with the mouse genotype (WT vs. Fmr1 KO) at P45.
(A) Photomicrographs of FosB/FosB-immunopositive cell nuclei in the
Sub, CA3, DG, EC, and LA. Scale bar: 25μm. (B) Bar graphs of cellular
density based on counts of FosB/FosB-immunopositive cell nuclei per
mm2 in Sub, CA1, CA3 and DG. (C) Bar graphs of cellular density based
on count of FosB/FosB-immunopositive cell nuclei per mm2 in preSub,
EC and LA. ∗P < 0.05, ∗∗P < 0.01, acoustically stimulated group vs. the
respective unstimulated group; ##P < 0.01, Fmr1 KO vs. WT mice with
similar treatment (tested or not tested). Three-way ANOVA followed by
LSD test. C-WT, WT mice not exposed to auditory stimulus; T-WT, WT
mice exposed to the audiogenic test, C-KO, Fmr1 KO mice not exposed
to auditory stimulus; T-KO, Fmr1 KO mice tested; Sub, subiculum; CA,
cornu Ammonis; DG, dentate gyrus; EC, entorhinal cortex; LA, lateral
amygdala.
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(C-WT; Figure 2A), while it increased after the acoustic test
(T-WT) in several brain regions and it reached statistical sig-
nificance (P < 0.01, LSD test) in the subiculum, CA1, dentate
gyrus, lateral amygdala (Figures 2B,C) and primary acoustic area
(Figures 3A,B). A significant (P < 0.05) increase was present also
in the CA3 hippocampal region (Figures 2A,B). Interestingly, in
non-stimulated P45 Fmr1 KO mice, FosB/FosB values were
significantly higher than in WT mice already in basal condi-
tions (C-KO in Figures 2A,B), particularly in the hippocampus
proper (P < 0.01 for CA1) and in the subiculum (P < 0.01;
Figure 2B). Following exposure to the test for AGS, FosB/FosB
immunoreactivity was significantly increased in P45 Fmr1 KO
mice (T-KO in Figures 2A–C) in the hippocampus (P < 0.05
for CA1 and P < 0.01 for CA3), subiculum (P < 0.05), dentate
gyrus (P < 0.05), lateral amygdala (P < 0.05), medial genicu-
late body (P < 0.05, Figure 3A), and primary acoustic cortex
(P < 0.05, Figures 3A,B) compared with unstimulated Fmr1 KO
mice, while it was unchanged in the presubiculum and entorhinal
cortex (Figures 2A,C). In addition, in the CA3 region the density
of immunopositive neurons was significantly (P < 0.01) higher
in P45 Fmr1 KO mice after the test compared with age-matched
WT also exposed to the testing procedure. A significant difference
(P < 0.05) between the two genotypes, after the auditory test, was
also found in the medial geniculate body (P < 0.05, Figure 3A),
but not in other sampled areas (Figures 2B,C, 3A).
Following exposure to the test for AGS of P90 mice, FosB/
FosB immunoreactivity was not increased in Fmr1 KO mice
(T-KO; Table 1) compared with unstimulated P90 Fmr1 KOmice
(C-KO; Table 1) in none of the sampled areas, including acoustic
regions. In addition, no differences were found in age-matched
WT mice (T-WT; Table 1) also exposed to the testing procedure.
The statistical analysis (Three-Way ANOVA) revealed main
effects of test exposure in the subiculum (P < 0.05), CA3
(P < 0.05), dentate gyrus (P < 0.01) and amygdala (P < 0.05).
The different genotype did not affect the level of FosB/FosB
immunoreactivity in any of the sampled regions, whereas age-
related changes were found in the subiculum (P < 0.05) and CA3
(P < 0.05). Interestingly, a significant interaction of all the 3main
factors (genotype × test × age) was present only in the subiculum
(P < 0.05). In the hippocampal CA1 and CA3 subfields, as well
as in the subiculum, significant (P < 0.01 for all regions) interac-
tions between test exposure and age, as well as between genotype
and age (P < 0.01 for all regions) were present. Significant inter-
actions between test exposure and age were present in the dentate
gyrus (P < 0.01) and entorhinal cortex (P < 0.01); in the lat-
ter we also found a significant interaction between age and
FIGURE 3 | FosB/FosB immunostaining in acoustic structures after
exposure to the test for audiogenic seizure induction and in relation
with the mouse genotype (WT vs. Fmr1 KO) at P45. (A) Bar graphs of
cellular density based on counts of FosB/FosB-immunopositive cell nuclei
per mm2 in the MGB and Au1. ∗P < 0.05, ∗∗P < 0.01, acoustically stimulated
group vs. the respective unstimulated group; #P < 0.05, Fmr1 KO vs. WT
mice with similar treatment (tested or not tested). Three-way ANOVA
followed by LSD test. (B) Photomicrographs of FosB/FosB-immunopositive
cell nuclei in Au1. Scale bar: 25μm. C-WT, WT mice not exposed to auditory
stimulus; T-WT, WT mice exposed to the audiogenic test; C-KO, Fmr1 KO
mice not exposed to auditory stimulus; T-KO, Fmr1 KO mice tested; MGB,
medial geniculate body; Au1, primary acoustic cortex.
Table 1 | Cellular density based on count of FosB/FosB-immunopositive cell nuclei per mm2 in Fmr1 KO and WT mice studied at age P90.
Sub CA1 CA3 DG preSub EC LA MGB Au1
C-WT 117 ± 20 87 ± 40 45 ± 60 89 ± 40 25 ± 90 27 ± 60 ND 13 ± 20 47 ± 70
T-WT 67 ± 11 34 ± 21 29 ± 20 71 ± 12 25 ± 22 12 ± 50 ND 25 ± 50 32 ± 70
C-KO 76 ± 42 59 ± 37 20 ± 10 35 ± 16 12 ± 11 10 ± 70 ND 36 ± 16 33 ± 80
T-KO 79 ± 45 42 ± 20 14 ± 80 79 ± 45 14 ± 80 12 ± 10 ND 25 ± 80 78 ± 13
No significant differences were found. It was not possible to sample a sufficient number of animals for lateral amygdala (LA).
C-WT, WT mice not exposed to auditory stimulus; T-WT, WT mice exposed to the acoustic test; C-KO, Fmr1 KO mice not exposed to auditory stimulus; T-KO,
Fmr1 KO mice tested; Sub, subiculum; CA, cornu Ammonis; DG, dentate gyrus; preSub, presubiculum; EC, entorhinal cortex; LA, lateral amygdala; MGB, medial
geniculate body; Au1, primary acoustic area; ND, not determined.
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genotype (P < 0.05). No significant interactions were found in
the amygdala. The analyzed acoustic regions presented with sig-
nificant effects of test (P < 0.05 for the medial geniculate body;
P < 0.01 for the primary acoustic region) and age (P < 0.05 for
the medial geniculate body; P < 0.01 for the primary acoustic
region), as well as significant interactions between test exposure
and age (P < 0.05 for the medial geniculate body; P < 0.01 for
the primary acoustic region).
CHANGES OF ERK1/2 ACTIVATION IN RELATION TO SEIZURES AND AGE
As further marker of neuronal activation, we evaluated p-ERK1/2
immunoreactivity in basal conditions and after the test (Figures 4
and 5). In limbic structures, p-ERK1/2-immunoreactive cells
were consistently observed in the subiculum and perirhinal
cortex of both strains. Sparse immunopositive cells were also
present in other regions in few mice. Thus, we focused on
the subiculum and perirhinal cortex to analyze changes in
p-ERK1/2-immunoreactive cell counts due to test exposure. In
the subiculum, p-ERK1/2-immunoreactive cells were located
in the pyramidal cell layer, as in the case of FosB/FosB-
immunopositive cells (cf. Figure 2A). The Three-way ANOVA
revealed a significant (P < 0.05) effect of age and a significant
(P < 0.01) interaction of genotype and test. Notably, a significant
(P < 0.01) interaction among genotype, age and test was also
present. Interestingly, a significant large number of p-ERK1/2-
immunopositive cells was already detectable in basal conditions
FIGURE 4 | Immunostaining of p-ERK1/2 in subiculum (Sub) after
exposure to the test for audiogenic seizure induction and in relation
with the mouse genotype (WT vs. Fmr1 KO) and the age (P45 and P90).
(A) Bar graphs of cellular density based on counts of p-ERK1/2-immuno-
positive cell nuclei per mm2 in Sub. (B) Photomicrographs of p-ERK1/2-
immunopositive cells in the Sub of P90 mice of both genotypes. Scale bar:
100μm. C-WT, WT mice not exposed to auditory stimulus; T-WT, WT mice
exposed to the audiogenic test; C-KO, Fmr1 KO mice not exposed to auditory
stimulus; T-KO, Fmr1 KO mice tested. O0.1 < P < 0.05, ∗P < 0.05,
∗∗P < 0.01, acoustically stimulated group vs. the respective unstimulated
group; #P < 0.05, ##P < 0.01, Fmr1 KO vs. WT mice with similar treatment
(tested or not tested). Three-way ANOVA followed by LSD test.
Frontiers in Cellular Neuroscience www.frontiersin.org April 2013 | Volume 7 | Article 46 | 6
Curia et al. Audiogenic seizures in Fragile X Syndrome
in Fmr1 KO (Figure 4B), both in P45 and P90 groups of age
(P < 0.05, Fisher’s LSD test; Figure 4A). After exposure to the
AGS test, p-ERK1/2-immunoreactive cells did not change signif-
icantly at P45 in both genotypes (but a trend toward increase
was present in P45 WT mice; P = 0.06 vs. basal values), whereas
a remarkable decrease (−75%) was observed in Fmr1 KO mice
at P90 (P < 0.05, Figure 4). This change was at variance with
the significant (P < 0.01 vs. basal levels in WT) increase in p-
ERK1/2 levels observed in WT rats exposed to AGS induction.
Thus, at P90, after exposure to the AGS test, levels of p-ERK1/2-
immunopositive cells in Fmr1 KO mice were significantly less
than in tested WT (P < 0.01; Figure 4).
Neuronal immunolabelling with the anti-p-ERK1/2 anti-
body was consistently observed also in the superficial layers
of perirhinal cortex. We analyzed the pattern of p-ERK1/2
immunoreactivity and found them to be similar both in P45
and P90 groups and independent of exposure to the AGS test
(Figure 5).
CHARACTERIZATION OF p-ERK1/2-IMMUNOPOSITIVE CELLS
We investigated whether neurons identified by FosB/FosB and
p-ERK1/2 antibodies were the same cells or, instead, distinct
elements. Experiments of co-labeling with FosB/FosB and
p-ERK1/2 antibodies in P45 mice revealed that approximately
50% of p-ERK1/2-immunopositive cells expressed FosB/FosB
antigens, whereas the other 50% was composed by distinct neu-
ronal elements, both in subiculum (Figures 6A–C) and perirhinal
cortex (Figures 6D–I), independently of the genotype.
FIGURE 5 | Immunostaining of p-ERK1/2 in perirhinal cortex (PRh)
after exposure to the test for audiogenic seizure induction and in
relation with the mouse genotype (WT vs. Fmr1 KO) and the
age (P45 and P90). (A) Bar graphs of cellular density based on
counts of p-ERK1/2-immunopositive cell nuclei per mm2 in PRh. (B)
Photomicrographs of p-ERK1/2-immunopositive cells in the PRh of P90
mice of both genotypes. Scale bar: 100μm. C-WT, WT mice not
exposed to auditory stimulus; T-WT, WT mice exposed to the
audiogenic test; C-KO, Fmr1 KO mice not exposed to auditory
stimulus; T-KO, Fmr1 KO mice tested.
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FIGURE 6 | Photomicrographs illustrating double immunofluorescence
experiments with antibodies against p-ERK1/2 and FosB/FosB
in three exampled mice. (A–C) illustrate the co-labeling of subicular
neurons in a Fmr1 KO mouse at P45. (D–F) demonstrate the
co-labeling found in the perirhinal cortex of a WT mouse at P45.
(G–I) Neurons co-labeled in the perirhinal cortex of a WT mouse
showed at higher magnification. Scale bars, 50μm for (A–F), 25μm
for (G–I).
We also explored the possibility that p-ERK1/2-immuno-
positive cells could be interneurons. Experiments of co-labeling
with p-ERK1/2 and markers for specific interneuron subclasses
were performed in the subiculum(Figure 7) and perirhinal cortex
(not shown). These experiments demonstrated that parvalbu-
min, neuropeptide Y and somatostatin antibodies, respectively,
did not co-localize with cells stained with p-ERK1/2 antibodies
(Figure 7).
DISCUSSION
We investigated the response to the AGS test at two different
ages in mice characterized by the Fmr1 KO genotype, compared
with age-matched control WT mice. As previously reported,
FXS patients (Ferri et al., 1994; Miller et al., 1999) and mice
(Musumeci et al., 2000) show anomalous reaction to sensory
stimuli and our experiments confirm the hyper-reaction of Fmr1
KOmice to loud acoustic stimulus (∼122 dB), given using a door-
bell mounted inside the experimental cage. This experimental
design gave us the possibility to test either the reaction to sen-
sory stimuli, either the susceptibility to AGS. Reportedly, seizure
susceptibility in the FXS is age-dependent: C57BL/6 Fmr1 KO
mice showed higher susceptibility between P15 and P47, while it
is between P14 and P94 in FVB Fmr1 KO mice (Musumeci et al.,
2000, 2007; Yan et al., 2005). This is confirmed in our experiments
where P45 C57BL/6 Fmr1 KO mice showed higher susceptibility
to AGS than P90 mice. Clinical investigations reported that
seizures are found in a small but significant subpopulation of FXS
patients during the infancy and usually disappear with matura-
tion (Hagerman and Stafstrom, 2009; Gauthey et al., 2010). The
presently reported findings and previous works in the FXS animal
model suggest that high homology exists between Fmr1 KO mice
and the humans with FXS.
We also analyzed the neuronal networks participating in the
seizure activity in Fmr1 KO mice. In particular, we analyzed
FosB/FosB expression as an alternative to previous studies based
on c-Fos immunoreactivity (Chen and Toth, 2001), another tool
being used for many years to track acute changes in neuronal
network activity. The analysis of FosB/FosB expression presents
several advantages, since c-Fos reliability has been questioned in
cases of recurrent neuronal synchronization, like the one typical
of epileptic animals (Mello et al., 1996). Moreover, the turnover of
c-Fos is very rapid when compared to that of other markers, such
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FIGURE 7 | Photomicrographs illustrating double immunofluorescence
experiments with antibodies against p-ERK1/2 and markers of
interneurons. In particular, antibodies to parvalbumin (top panels),
somatostatin (middle panels) or neuropeptide Y (NPY; bottom panels)
did not co-localize with p-ERK1/2-immunopositive cells. Scale bar:
25μm.
as FosB and FosB (Madsen et al., 2006), making c-Fos expres-
sion extremely short living. In contrast, thanks to their stability,
products of the fosB gene family tend to accumulate in repeatedly
activated neurons (Chen et al., 1997; Kelz and Nestler, 2000),
being the ideal tool available now to investigate network activity
in epileptic animals (Chen et al., 1997; Biagini et al., 2005;Madsen
et al., 2006). As expected, the acoustic stimulus induced an
increased labeling for FosB/FosB in regions involved in process-
ing auditory information, especially in the medial geniculate body
and primary acoustic area, both in WT and Fmr1 KO mice, indi-
cating that acoustic pathways had been activated. These findings
are consistent with those by Chen and Toth (2001), demonstrat-
ing increased c-Fos expression after acoustic stimulus in specific
thalamic regions of the FXS genotype, such as the medial genic-
ulate body, compared to stimulated WT mice. We also observed
enhanced FosB/FosB immunoreactivity in the medial genicu-
late body of Fmr1 KO compared with WT stimulated mice. At
variance, no differences between the two genotypes were present
in FosB/FosB expression in the primary acoustic area, a result
that is also in agreement with c-Fos immunodetection (Chen and
Toth, 2001).
Basal levels of FosB/FosB immunoreactivity in the medial
geniculate body and primary acoustic area were similar in both
genotypes, but a different scenario emerged in the hippocam-
pal formation, in which FosB/FosB immunoreactivity was
unexpectedly higher in unstimulated P45 Fmr1 KO mice com-
pared to age-matched WTs, suggesting that regions notoriously
involved in cognitive and emotional physiological functions (Koe
et al., 2009; Herry et al., 2010) were hyperactive in our animal
model of FXS. These differences were previously unreported in
experiments based on antibodies to c-Fos (Chen and Toth, 2001;
Li et al., 2002). However, the hippocampus is responsive to acous-
tic stimuli (Miller and Freedman, 1995) and, as shown in other
models, there is a good evidence that some hippocampal regions
are strictly related to the formation of memory traces of acoustic
information (Huang et al., 2010). The link among acoustic infor-
mation, seizures and the hippocampus has also been confirmed
by evaluating patients affected by TLE (Boutros et al., 2008).
In TLE, the hippocampus is consistently involved in epileptic
neuronal synchronization (Avoli et al., 2002), thus the enhanced
immunopositivity for FosB/FosB found in the CA1 region and
in the subiculum of Fmr1 KO mice not exposed to the acoustic
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test could be interpreted as caused by unobserved spontaneous
seizures. Alternatively, differences in the response to environ-
mental stimuli or to stress could be taken into account (Miller
et al., 1999; Lauterborn, 2004). The CA1 subfield is involved in
the termination of the stress response by regulating the neuroen-
docrine axis that controls corticosterone levels, a function that
strictly integrates the effects of stress with memory processing
(Joëls et al., 2009). This hippocampal region is especially sensi-
tive to stressful stimuli and can be markedly altered by chronic
stress exposure both during development (Biagini et al., 1998)
and in the adulthood (Biagini et al., 1993), circumstances that
result in the impairment of stress response termination. Evenwith
slightly different results, most likely due to the different type and
duration of stress and the different time after stress when tis-
sue was collected, others also demonstrated that changes in c-fos
gene expression induced by stress are greater in Fmr1 KO com-
pared toWTmice (Lauterborn, 2004). In addition, the increase in
corticosterone levels is greater in FXS mice compared to WT sub-
jected to the same type of stress (Lauterborn, 2004). In analogy
to patients affected by FXS, Fmr1 KO mice presented with a pro-
longed return to basal corticosterone levels in response to acute
stress, which could be related to an altered hippocampal feedback
regulation (Markham et al., 2006).
We have evaluated a second marker of neuronal cell activity
by characterizing p-ERK1/2-immunopositive cells. ERK is mem-
ber of the mammalian mitogen-activated protein kinase (MAPK)
family of serine/threonine kinases and regulates a variety of phys-
iological and pathophysiological cellular activities (Subramaniam
et al., 2004). This is a marker alternative to FosB. ERK1/2 phos-
phorylation is known to be followed by c-Fos activation. c-Fos
phosphorylation is catalyzed by ERK1/2 at Ser374 and, further-
more, the further downstream reaction at Ser362 stabilizes c-Fos
for several hours (Okazaki and Sagata, 1995; Murphy et al.,
2002). No regulatory effects on FosB are instead reported by
ERK1/2 activation (Miller et al., 1998). Accordingly, transacti-
vation by c-Fos is mediated by two C-terminal motifs named
HOB1 and HOB2, of which HOB1, absent in FosB (Herdegen
and Leah, 1998), can be phosphorylated by ERK1/2. Consistently,
our findings on FosB and p-ERK1/2 co-labeling demonstrate
only a partial superimposition of these markers, suggesting that
activated neurons were indeed responsive to different molecular
pathways. It has been proposed a critical role for ERK1/2 in reg-
ulating social behaviors, and it has been suggested that it may
be an important factor in human psychiatric disorders (Engel
et al., 2009; Satoh et al., 2011). Interestingly, Hou et al. (2006)
and Price et al. (2007) showed that the basal p-ERK1/2 levels
in hippocampal synaptosomes were elevated in Fmr1 KO mice
compared to WTs, but p-ERK1/2 could not be increased by stim-
ulating metabotropic glutamate receptor (mGluR) as instead in
WT mice. There is, however, some controversy in the literature
regarding ERK1/2 activation in Fmr1 KO tissue (Hu et al., 2008;
Gross et al., 2010) and given its critical role in synaptic plasticity,
as well as in neurodevelopment and regulation of social behaviors,
Wang and colleagues (2012) decided to investigate further this
question using human brain tissue obtained from FXS patients.
For the first time, they demonstrated that ERK1/2 phosphoryla-
tion is altered in neocortex and hippocampus of FXS patients,
suggesting that there is a chronic activation of the MAPK/ERK
kinase (MEK)-ERK1/2 pathway; in addition they confirmed these
results in cortical tissue obtained from Fmr1 KO mice (Wang
et al., 2012). Similar upregulation of p-ERK1/2 in Fmr1 KO mice
was also found by Michalon et al. (2012). In line with these data,
we observed a higher level of p-ERK1/2-immunopositive cells in
basal conditions, but this difference was specifically found in the
subiculum of Fmr1 KO mice. This finding does not exclude that
in fresh tissue, studied with different techniques (Michalon et al.,
2012; Wang et al., 2012), enhanced ERK1/2 phosphorylation is
found in other brain regions, but the subiculum could anyway
represent an area of prominent ERK1/2 activation in the FXS
model.
Activation of ERK1/2 by phosphorylation is strongly pro-
moted by glutamate release during seizures and by stimulation
of glutamate receptors (Jeon et al., 2000; Otani et al., 2003;
Merlo et al., 2004; Houser et al., 2008). Interestingly, inhibi-
tion of ERK1/2 phosphorylation was shown to decrease in vitro
ictogenesis induced by 4-aminopyridine (Merlo et al., 2004).
Consistently with these data, a constitutively active form ofMEK1
induced ERK1/2 activation and caused spontaneous epileptic
seizures when conditionally expressed in the murine brain (Nateri
et al., 2007). Recent experiments have cleared the relationship
between ERK1/2 phosphorylation and the occurrence of AGS.
Using the inhibitor of the MEK-ERK1/2 kinase cascade U0126,
three different laboratories were able to block AGS in Fmr1 KO
mice (Osterweil et al., 2010; Michalon et al., 2012; Wang et al.,
2012). To this regard, we found that p-ERK1/2 immunoreactiv-
ity is decreased in the subiculum, but not in perirhinal cortex,
of Fmr1 KO mice not manifesting AGS in response to acous-
tic stimulation. At variance, no significant changes of p-ERK1/2
immunoreactivity were observed in mice presenting with AGS
induction. On the other hand, p-ERK1/2 levels were upregu-
lated by the acoustic test in WT mice, in which we did not
observe any epileptic response. This discrepancy suggests a differ-
ential regulation of ERK1/2 activity in normal and epilepsy-prone
animals. Using pilocarpine to induce seizures, Houser and col-
leagues (2008) actually observed a decrease in p-ERK1/2 levels
in naïve mice, whereas ERK1/2 phosphorylation increased imme-
diately before the appearance of recurrent spontaneous seizures
in the animals that experienced the pilocarpine-induced status
epilepticus. Thus, it is possible that the enhanced phosphoryla-
tion of ERK1/2 observed in WTmice in the subiculum represents
a molecular fingerprint of the exposure to subthreshold pro-
convulsive stimuli in presence of a normal genotype, whereas
the increase of p-ERK1/2 basal levels found in Fmr1 KO mice
could be related to a proconvulsive genotype. In addition, an
inefficient p-ERK1/2 dephosphorylation in the subiculum of
Fmr1 KO mice appears to be responsible for AGS induction,
whereas enhanced phosphatase activity, acquired during matura-
tion, could explain the resilience to proconvulsive stimuli in older
Fmr1 KO mice. This overall evidence suggests that abnormally
elevated and timely maintained p-ERK1/2 levels in the subicu-
lum are required for AGS induction in Fmr1 KO mice. Notably,
the changes we found in p-ERK1/2 levels were age-dependent,
suggesting that this mechanism could be involved in the modi-
fication of seizure susceptibility during maturation in the FXS.
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Contrary to results obtained in the subiculum, no differ-
ences at all were observed in the perirhinal cortex of WT
and Fmr1 KO mice exposed to the test for AGS induction.
This result is consistent with previous findings that showed
defective neurotransmission in the subiculum of Fmr1 KO
mice (D’Antuono et al., 2003; Curia et al., 2009). In particu-
lar, p-ERK1/2 was shown to display regulatory properties on
γ-aminobutyric acid (GABA) type A receptors by decreasing
peak currents generated by α1β2γ2 combination of subunits,
an effect prevented by UO126 treatment (Bell-Horner et al.,
2006). This effect on GABA peak current could be particularly
important in a background of decreased GABA tonic current,
such as that found in Fmr1 KO mice (Curia et al., 2009). The
subiculum from patients affected by TLE, due to hippocampal
sclerosis, was found to generate spontaneous epileptic activity
in vitro (Cohen et al., 2002). Consistently, enhanced neuronal
excitability was demonstrated in the subiculum of pilocarpine-
treated rats, a model of TLE associated with brain damage,
in which GABAergic neurons were significantly decreased (De
Guzman et al., 2006). Thus, the present findings on markedly
enhanced FosB/FosB levels and p-ERK1/2 expression in the
subiculum of Fmr1 KO mice further support the view of a
critical role of this limbic region in controlling the spread of
seizure activity in neuronal networks also in models of genetic
epilepsy.
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